MDCX READ THE FULL MDCX RESEARCH REPORT READ THE FULL V.MDCX RESEARCH REPORT Third Quarter 2024 Financial Results On November ...

MDCX READ THE FULL V.MDCX RESEARCH REPORT IPO in U.S. Provides Additional Funding & Common Stock that Trades on Nasdaq On ...

Medicus Pharma Ltd (TSE:MDCX) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - ...

Within the Netherlands, South Holland emerged as one of the most prominent provinces, housing 21 per cent of all startups and ...

TORONTO and PHILADELPHIA, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd (NASDAQ: MDCX TSXV: MDCX) (the “Company”) is pleased to announce the appointment of Faisal Mehmud, MD as Chief Medical ...

Wearable diagnostics are poised to transform subjective, episodic measures of disease progression to quantified, continuous ...

non-invasive treatment for basal cell skin cancer using patented dissolvable microneedle patch to deliver chemotherapeutic agent to eradicate tumors cells. The Company has completed a phase 1 ...

We aim to capitalize on his experience and expertise to expand our drug development pipeline and foster collaboration with strategic partners to bring to market our novel non-invasive patented ...

Keywords: Microneedle Technology, Microneedles, Drug Delivery, Personalized Medicine, Transdermal, Intradermal, Targeted Delivery Systems Important Note: All contributions to this Research Topic must ...